Vrisko Limited announces agreement with a leader company in production of monoclonal antibodies
PR Log - Jan 24, 2012 - The English company Vrisko Limited, which is specialized in providing biotech products and services, is happy to announce that it has a distribution agreement with Creative Diagnostics, a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents, with based in New York, USA. Vrisko Limited is taking a place in the English and European biotech market by distributing different products and services including monoclonal antibodies and recombinants proteins. Creative Diagnostics has provided a non-exclusive distribution right to supply the UK markets with their products and services.
“this agreement is important for us since this company is a leader in production of monoclonal antibodies and recombinant proteins which will open a new market for us in this field. We think that it will increase the need of monoclonal antibodies since these molecules are widely used as tools in research and in clinics which is creating a great opportunity for us” said the representative of the company.
Vrisko limited has approached several leaders in the production of monoclonal antibodies including human monoclonal antibodies and therapeutic antibodies and state-of the art technologies as antibody engineering to cover the necessity of these types of products in research and medicine. Vrisko limited is adopting a market approach to providing custom services and products put together as project proposal to fit best the needs of its customers.